Disease: Subvalvular aortic stenosis
- A bibliometric and visual analysis of research trends and hotspots of familial hypertrophic cardiomyopathy: A review
- A case of hypertrophic cardiomyopathy with previous aortic valve replacement
- A New Leu714Arg Variant in the Converter Domain of <em>MYH7</em> is Associated with a Severe Form of Familial Hypertrophic Cardiomyopathy
- A Novel CMR-ECGI Lens Exposes the Electrophysiological Substrate in Subclinical HCM: A Glimmering Future Preview
- A novel gene-trap line reveals the dynamic patterns and essential roles of cysteine and glycine-rich protein 3 in zebrafish heart development and regeneration
- A pilot study for risk stratification of ventricular tachyarrhythmia in hypertrophic cardiomyopathy with routine echocardiography parameters
- A rare homozygous mutation in the YARS2 gene presents with hypertrophic cardiomyopathy, lactic acidosis and anemia in a Chinese infant
- A therapeutic leap: how myosin inhibitors moved from cardiac interventions to skeletal muscle myopathy solutions
- Aberrant Myocardial Dynamics in Subclinical Hypertrophic Cardiomyopathy
- Accurate diagnosis of apical hypertrophic cardiomyopathy using explainable advanced electrocardiogram analysis
- Advances in the Management of Hypertrophic Cardiomyopathy Leading to Low Disease-Related Mortality in 2023
- Aggressive treatment of atrial fibrillation in hypertrophic cardiomyopathy patients improve quality of life
- Alternative Approaches for Alcohol Septal Ablation in Hypertrophic Cardiomyopathy: The Call for a Personalized Treatment
- An <em>In Silico</em> Cardiomyocyte Reveals the Impact of Changes in CaMKII Signalling on Cardiomyocyte Contraction Kinetics in Hypertrophic Cardiomyopathy
- Anderson-Fabry disease management: role of the cardiologist
- Are Cardiac Myosin Inhibitors Useful in Patients With Hypertrophic Obstructive Cardiomyopathy and Comorbid Hypertension?
- Association of Impaired Left Ventricular Mitral Filling from 4D Flow Cardiac MRI and Prognosis of Hypertrophic Cardiomyopathy
- Cardiac Magnetic Resonance Feature-Tracking Identifies Preclinical Abnormalities in Hypertrophic Cardiomyopathy Sarcomere Gene Mutation Carriers
- Cardiomyopathies in children and adolescents: aetiology, management, and outcomes in the European Society of Cardiology EURObservational Research Programme Cardiomyopathy and Myocarditis Registry
- Cardiotoxicity Risk of Cancer Treatment in Patients With Underlying Cardiomyopathies: Is Hypertrophic Cardiomyopathy Any Different?
- Chinese expert consensus on the diagnosis and treatment of adult Fabry disease cardiomyopathy
- Circular RNAs: Biogenesis, Functions, and Role in Myocardial Hypertrophy
- Clinical characteristics and outcomes of alcohol septal ablation in the era of transcatheter valve interventions
- Combined transaortic/transapical left ventricular septal myectomy for subaortic and midventricular obstruction in a paediatric patient
- Comparative Evaluation of Alcohol Septal Ablation: Left Anterior Descending Versus Non-left Anterior Descending Artery Approaches
- Comparison of Early and Mid-Term Outcomes After Classic and Modified Morrow Septal Myectomy in Patients with Hypertrophic Obstructive Cardiomyopathy
- Coronary microvascular dysfunction: prevalence and aetiology in patients with suspected myocardial ischaemia
- Correlations of IL-1 and IL-6 Gene polymorphisms with hypertrophic cardiomyopathy
- Diagnostic value of LGE and T1 mapping in multiple myeloma patients'heart
- Differences Between Two Distinct Hypertrophic Cardiac Conditions: Fabry Disease versus Hypertrophic Cardiomyopathy
- Disease features and management of cardiomyopathies in women
- Downregulation of salusins alleviates hypertrophic cardiomyopathy via attenuating oxidative stress and autophagy
- Effect of Personalized Accelerated Pacing in Patients With Nonobstructive Hypertrophic Cardiomyopathy
- Electrophysiological Characterization of Subclinical and Overt Hypertrophic Cardiomyopathy by Magnetic Resonance Imaging-Guided Electrocardiography
- Estimating the risk of sudden death in hypertrophic cardiomyopathy might be solved by artificial intelligence
- Evaluating convolutional neural network-enhanced electrocardiography for hypertrophic cardiomyopathy detection in a specialized cardiovascular setting
- Evaluating the efficacy and safety of mavacamten in hypertrophic cardiomyopathy: A systematic review and meta-analysis focusing on qualitative assessment, biomarkers, and cardiac imaging
- Evaluation the relationship between myocardial fibrosis and left ventricular torsion measured by cardiac magnetic resonance feature-tracking in hypertrophic cardiomyopathy patients with preserved ejection fraction
- Evolving indications for transcatheter mitral edge-to-edge repair
- FARS2 Deficiency Causes Cardiomyopathy by Disrupting Mitochondrial Homeostasis and the Mitochondrial Quality Control System
- Feasibility and prognostic value of tissue motion annular displacement in patients with heart transplantation
- Focal ischemic myocardial fibrosis assessed by late gadolinium enhancement cardiovascular magnetic resonance in patients with hypertrophic cardiomyopathy
- Generation of induced pluripotent stem cell lines from two unrelated individuals with familial hypertrophic cardiomyopathy carrying MYBPC3 nonsense mutations
- Genetic Testing in Hypertrophic Cardiomyopathy
- Genetic Testing Yield and Clinical Characteristics of Hypertrophic Cardiomyopathy in Understudied Ethnic Groups: Insights From a New Zealand National Registry
- Genotype Influences Mavacamten Responsiveness in Obstructive Hypertrophic Cardiomyopathy
- Heart Failure and Hypertrophic Cardiomyopathy-Looking Back on Decades of Remarkable Progress
- How are the predictors of sudden death modified after septal myectomy surgery?
- Hypertrophic Cardiomyopathy: A Brief Overview
- Hypertrophic Cardiomyopathy: Preadolescence, Mitral Valve Disease, and Midventricular Obstruction
- Hypertrophic Cardiomyopathy: The Patient Perspective-Turning Tragedy into Action
- Implication of sleep apnea for cardiac remodeling in patients with hypertrophic cardiomyopathy
- Incomplete-penetrant hypertrophic cardiomyopathy <em>MYH7</em> G256E mutation causes hypercontractility and elevated mitochondrial respiration
- Left ventricular hypertrophy. Is there only hypertrophic cardiomyopathy?
- Left Ventricular Outflow Tract Obstruction After Transcatheter Aortic Valve Replacement due to Pannus Formation
- Long-Term Effects of Mavacamten on Electromechanical Dispersion and Deformation in Obstructive Hypertrophic Cardiomyopathy
- Long-term post-transplantation outcomes in patients with hypertrophic cardiomyopathy: Single-center 35-year experience
- Long-Term Safety and Efficacy of Mavacamten in Symptomatic Obstructive Hypertrophic Cardiomyopathy: Interim Results of the PIONEER-OLE Study
- Maintenance of Subcutaneous Implantable Cardioverter Defibrillators in Hypertrophic Cardiomyopathy Patients With Iatrogenic Left Bundle-Branch Block After Septal Myectomy
- Mavacamten (Camzyos ®) : first myosin modulator for obstructive hypertrophic cardiomyopathy treatment
- Mavacamten (CAMZYOS) First-in-Class Small-Molecule Myosin Inhibitor for Treatment of Obstructive Hypertrophic Cardiomyopathy
- Medical Treatment Strategies for Hypertrophic Cardiomyopathy
- Metabolic profiling of aortic stenosis and hypertrophic cardiomyopathy identifies mechanistic contrasts in substrate utilization
- Mid-ventricular Hypertrophic Obstructive Cardiomyopathy in a Patient Whose Hemodynamics Were Exacerbated by Forward Shift of the Posterior Leaflet Caused by Mitral Annular Calcification
- Mildly Reduced Renal Function Is Associated With Increased Heart Failure Admissions in Patients With Hypertrophic Cardiomyopathy
- Multiplexed Functional Assessments of <em>MYH7</em> Variants in Human Cardiomyocytes
- Myocardial bridging in obstructive hypertrophic cardiomyopathy: a risk factor for myocardial fibrosis
- Myosin folding boosts solubility in cardiac muscle sarcomeres
- NAA10 gene related Ogden syndrome with obstructive hypertrophic cardiomyopathy: A rare case report
- Pathological causes of sudden death in autopsied children with reference to peculiar findings: An Egyptian perspective
- Pooled Genetic Screenings to Identify Likely Pathogenic Variants in Hypertrophic Cardiomyopathy
- Post-hoc standardisation of parametric T1 maps in cardiovascular magnetic resonance imaging: a proof-of-concept
- Practice guidance for stress echocardiography
- Predictive value of estimated plasma volume for postoperative hypotension in percutaneous intramyocardial septal radiofrequency ablation treating for hypertrophic obstructive cardiomyopathy
- Prevalence and phenotypes associated with ALPK3 null variants in a large French multicentric cohort: Confirming its involvement in hypertrophic cardiomyopathy
- Quantification of myocardial scar of different etiology using dark- and bright-blood late gadolinium enhancement cardiovascular magnetic resonance
- Radiomics from Cardiovascular MR Cine Images for Identifying Patients with Hypertrophic Cardiomyopathy at High Risk for Heart Failure
- Re-evaluating the Incidence and Prevalence of Clinical Hypertrophic Cardiomyopathy: An Epidemiological Study of Olmsted County, Minnesota
- Remimazolam-based anesthesia in a patient with hypertrophic obstructive cardiomyopathy undergoing radical colorectal cancer surgery: A case report
- Resection of hypertrophic papillary muscles and mitral valve replacement in a patient with midventricular hypertrophic obstructive cardiomyopathy - a new approach
- Response to: Regard to assessing agreement between two raters with kappa statistics
- Role of experience in myectomy for hypertrophic cardiomyopathy: With very high procedural volume, myectomy remains low-risk even with concomitant procedure need
- Role of Imaging in the Diagnosis, Evaluation, and Management of Hypertrophic Cardiomyopathy
- Scar architecture affects the electrophysiological characteristics of induced ventricular arrhythmias in hypertrophic cardiomyopathy
- Short time effects of two radiofrequency ablation methods on hypertrophic obstructive cardiomyopathy
- Structural and Functional Impact of Adrenoceptor Beta-1 Gene Polymorphism in Patients with Hypertrophic Cardiomyopathy and Response to Beta-Blocker Therapy
- Targeted Sequencing of Circular RNAs for Illumina-Based Counting and Nanopore Structure Determination
- The Majority of Participants With Suspected Hypertrophic Cardiomyopathy Documented During Screening Echocardiography Have a Normal Electrocardiogram
- The Paradigm of Sudden Death Prevention in Hypertrophic Cardiomyopathy
- The weight of obesity in hypertrophic cardiomyopathy
- Towards etiological treatments in cardiomyopathies
- Transapical intramyocardial septal microwave ablation in treatment of hypertrophic obstructive cardiomyopathy: 12-month outcomes of a swine model
- Transcatheter Myotomy for LVOT Challenges: SESAME Street 2.0
- Transcatheter Myotomy to Reduce Left Ventricular Outflow Obstruction
- Transcriptomic Analyses and Experimental Validation Identified Immune-Related lncRNA-mRNA Pair <em>MIR210HG</em>-<em>BPIFC</em> Regulating the Progression of Hypertrophic Cardiomyopathy
- Treatment Strategies for Hypertrophic Cardiomyopathy: Alcohol Septal Ablation and Procedural Step-by-Step Technique
- Treatment Strategies for Hypertrophic Cardiomyopathy: Surgical
- Trends of hypertrophic cardiomyopathy-related mortality in United States young adults: a nationwide 20-year analysis
- When radiation meets the heart: Future of stereotactic body radiation therapy for hypertrophic obstructive cardiomyopathy
- Why Ancestral Diversity in Genetic Testing Matters: Lessons Learned From Hypertrophic Cardiomyopathy